Market Place
Sourcing Support
Tarsier Pharma: Emilee Fulcher Named VP Of Clinical Affairs
28 May 2024 //
PR NEWSWIRE
Tarsier Receives FDA Agreement Under SPA for Tarsier-04 Phase 3 Trial of TRS01
16 Jan 2024 //
PR NEWSWIRE
Tarsier Pharma Announces Successful Type C Meeting with FDA for TRS01
13 Nov 2023 //
PR NEWSWIRE
Tarsier Announces Results from Phase 3 in Subjects with TRS4VISION trial
23 Aug 2023 //
PR NEWSWIRE
Tarsier Announces Publication of Review Article on Suppressing Inflammation
12 Jun 2023 //
PR NEWSWIRE
Tarsier Pharma announces International Non-proprietary Name for TRS
24 Apr 2023 //
PR NEWSWIRE
Tarsier Pharma to participate in H.C. Wainwright Ophthalmology Conference
08 Aug 2022 //
PRNEWSWIRE
First Patient Dosed in Tarsier`s Phase 3 Trial in Uveitis with Uveitic Glaucoma
22 Sep 2021 //
BIOSPACE
Tarsier Pharma Raises Capital to Execute Phase-3 Clinical Trial
24 Aug 2021 //
PRNEWSWIRE
Tarsier Pharma Completes Successful Pre-IND Meeting with the FDA for its TRS02
26 Apr 2021 //
PRNEWSWIRE
Tarsier Pharma Completes Successful Pre-IND Meeting with the FDA for its TRS02
26 Apr 2021 //
PRNEWSWIRE
Tarsius Pharma Achieves Positive Results in Proof of Concept Study for TRS01
05 Oct 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.